Evidence map›Paper›PMID 31664105›Full record

ArticleScientific reports2019

FTIR, Raman and AFM characterization of the clinically valid biochemical parameters of the thrombi in acute ischemic stroke.

Aneta Blat, Jakub Dybas, Karolina Chrabaszcz, Katarzyna Bulat, Agnieszka Jasztal, Magdalena Kaczmarska, Roman Pulyk, Tadeusz Popiela, Agnieszka Slowik, Kamilla Malek and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
5.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Aneta BlatJagiellonian Center for Experimental Therapeutics, Jagiellonian University, 14 Bobrzynskiego Str., 30-348, Krakow, Poland.
Jakub DybasJagiellonian Center for Experimental Therapeutics, Jagiellonian University, 14 Bobrzynskiego Str., 30-348, Krakow, Poland.
Karolina ChrabaszczJagiellonian Center for Experimental Therapeutics, Jagiellonian University, 14 Bobrzynskiego Str., 30-348, Krakow, Poland.
Katarzyna BulatJagiellonian Center for Experimental Therapeutics, Jagiellonian University, 14 Bobrzynskiego Str., 30-348, Krakow, Poland.
Agnieszka JasztalJagiellonian Center for Experimental Therapeutics, Jagiellonian University, 14 Bobrzynskiego Str., 30-348, Krakow, Poland.
Magdalena KaczmarskaJagiellonian Center for Experimental Therapeutics, Jagiellonian University, 14 Bobrzynskiego Str., 30-348, Krakow, Poland.
Roman PulykDepartment of Neurology, Jagiellonian University Medical College, 3 Botaniczna Str., 31-503, Krakow, Poland.
Tadeusz PopielaDepartment of Neuroradiology, Jagiellonian University Medical College, 3 Botaniczna Str., 31-503, Krakow, Poland.
Agnieszka SlowikDepartment of Neurology, Jagiellonian University Medical College, 3 Botaniczna Str., 31-503, Krakow, Poland.
Kamilla MalekFaculty of Chemistry, Jagiellonian University, 2 Gronostajowa Str., Krakow, Poland.
Mateusz G AdamskiJagiellonian Center for Experimental Therapeutics, Jagiellonian University, 14 Bobrzynskiego Str., 30-348, Krakow, Poland.
Katarzyna M MarzecJagiellonian Center for Experimental Therapeutics, Jagiellonian University, 14 Bobrzynskiego Str., 30-348, Krakow, Poland. katarzyna.marzec@jcet.eu.
Jagiellonian University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The significance and utility of innovative imaging techniques in arterial clot analysis, which enable far more detailed and automated analysis compared to standard methods, are presented. The examination of two types of human thrombi is shown, representing the main ischemic stroke etiologies: fibrin-predominant clot of large vessel origin and red blood cells-rich clot of cardioembolic origin. The synergy effect of Fourier-transform infrared spectroscopy (FTIR), Raman spectroscopy (RS) and atomic force microscopy (AFM) techniques supported by chemometrics in comparison with reference histological staining was presented. The main advantage of such approach refers to free-label and non-destructive quantitative imaging of clinically valid, biochemical parameters in whole sample (FTIR-low resolution) and selected regions (RS-ultra-high resolution). We may include here analysis of lipid content, its distribution and total degree of unsaturation as well as analysis of protein content (mainly fibrin and hemoproteins). The AFM studies enhanced the vibrational data, showed clearly shape and thickness of clot features as well as visualized the fibrin framework. The extraordinary sensitivity of FTIR and RS imaging toward detection and discrimination of clinically valid parameters in clot confirms its applicability in assessment of thrombi origin.

Indexed as

Brain IschemiaHumansMicroscopy, Atomic ForceSpectroscopy, Fourier Transform InfraredSpectrum Analysis, RamanStrokeThrombectomyThrombosis

Identifiers

PMID31664105
PMCPMC6820737
OpenAlexW2982603005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.